Leading global biotherapeutics company CSL Limited has unveiled its new world-class manufacturing facility in Melbourne’s north, which will create life-saving medicine and hundreds of jobs.
Minister for Trade and Investment Philip Dalidakis joined Minister for Industry and Employment Ben Carroll at the opening of the $230 million Broadmeadows facility - which will create 200 new full time local jobs.
The facility will manufacture albumin – a protein derived from human plasma used in critical care to treat burns and shock.
CSL expects the facility to produce therapies with an estimated annual market value of $850 million with plans to export products to the United States and Europe, while also producing products for the local Australian market.
The company currently provides life-saving products to more than 60 countries and employs nearly 20,000 people with major facilities in Australia, China, the UK, Germany, Switzerland and the USA.
In Australia, CSL employs more than 2,000 people with 98 per cent of those in Victoria.
Victoria is a world-leader in the development and manufacture of biotechnology, medical technology, and pharmaceutical products with the recent State of the Sector Medical Technologies and Pharmaceuticals 2017 report showing that pharmaceutical manufacturing in Victoria is booming.
The medtech and pharmaceutical sector currently employs more than 23,000 people, generates over $12.7 billion in revenue and contributes over $1.35 billion in exports to the Victorian economy.
The Andrews Labor Government is driving jobs, investment and export growth in the medical technology and pharmaceutical sector through the Future Industries Fund.
Quote attributable to Minister for Trade and Investment Philip Dalidakis
“This is yet another example of an innovative company investing in Victoria to support our economy and create jobs, and we look forward to continuing to work with CSL well into the future.”
Quote attributable to Minister for Industry and Employment Ben Carroll
“Not only will this new facility produce life-saving medicine but it will also create hundreds of new jobs for Victoria.”
Quote attributable to Parliamentary Secretary for Medical Research and Member for Broadmeadows Frank McGuire
“CSL’s significant investment will save lives, enhance Victoria’s reputation as an international leader in medical research and adds jobs to the almost 1,000 people employed at the Broadmeadows site.”
Reviewed 19 August 2020